ARTICLE | Company News
Pathobiotek, MRL Inc. deal
January 11, 1999 8:00 AM UTC
The companies signed a letter of intent to develop diagnostics against an immune system-inhibiting organism that PBTK believes is involved in multiple sclerosis. PBTK will receive license fees and dev...